Search Results
Showing results 1 to 20 of 25.
Focus Area
Substance Use Research
Announcement
RTI International researchers awarded grant funding to explore drugs for chronic pain, cancer
January 08, 2019
RTI In The Media
After 20 Years of Research, RTI Drug Approved for Drug-Resistant Tuberculosis
August 14, 2019 - Triangle Business Journal
RTI In The Media
Research Triangle Park Home to Breakthrough in Combating Drug-Resistant Tuberculosis
November 12, 2019 - CBS 17
Impact
Taxol® and Camptothecin™
April 04, 2016
Impact
Mapping the Kappa Opioid Receptor Using RTI's JDTic Compound
April 04, 2016
Expert
Yanan Zhang
News Release
FDA Approves Breakthrough Drug to Treat Extensively Drug-Resistant Tuberculosis
August 14, 2019
Event
Southeast Regional Meeting of the American Chemical Society 2023 Annual Meeting
October 25, 2023
Impact
Ulipristal Acetate
April 11, 2016
Expert
Gabriel A. Knudsen
Focus Area
Preventing Substance Use
Expert
Mark Levi
News Release
RTI International Licenses Portfolio of Compounds to APIE Therapeutics
August 25, 2020
Impact
Novel Solutions: The Chemistry Center for Combating Antibiotic Resistant Bacteria (CC4CARB)
September 26, 2022
Expert
Kenneth Rehder
Expert
Chunyang Jin
Expert
Scott Runyon
Impact
An Alternative to Opioids: Targeting Cannabinoid Receptors for Relief of Neuropathic Pain
September 18, 2017
Announcement
Ruth E. Winecker Receives American Academy of Forensic Sciences Award for Outstanding Contributions in Forensic Toxicology
February 11, 2019